ConductScience.org, home

Paper26567992

Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion.

Ikeda A and 10 others. Intern Med, 2015. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion. Papers, record 26567992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26567992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion.
PubMed
Journal
Intern Med
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.8
iCite
Revised in PubMed
2026-01-27
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ikeda AAtsuki
2Hoshi NNamiko
3Yoshizaki TTetsuya
4Fujishima YYoshimi
5Ishida TTsukasa
6Morita YYoshinori
7Ejima YYasuo
8Toyonaga TTakashi
9Kakechi YYoshihiro
10Yokosaki HHiroshi
11Azuma TTakeshi

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
DissectionMajor topic
Esophageal NeoplasmsMajor topic
EsophagoscopyMajor topic
EsophagusMajor topic
Neoplasm Recurrence, LocalMajor topic
Aged
Chemoradiotherapy
Combined Modality Therapy
Female
Humans
Japan
Male
Middle Aged
Mucous Membrane
Neoplasm Staging
Quality of Life
Retrospective Studies
Survival Rate
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42626576Endoscopic Submucosal Dissection and Chemoradiotherapy versus Esophagectomy for T1a-m3 or T1b Esophageal Squamous Cell Carcinoma: A Meta-analysis.Endosc Int Open2026https://conductscience.org/library/papers/42626576PubMed
42564051Comparative efficacy and outcomes of different treatments for pathologically high-risk superficial esophageal cancer: a systematic review and network meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42564051PubMed
42488030Additional chemoradiotherapy versus esophagectomy for early esophageal cancer: an integrated analysis of reconstructed time-to-event data.Ther Adv Gastroenterol2026https://conductscience.org/library/papers/42488030PubMed
41943646Next step after endoscopic resection for superficial esophageal squamous cell carcinoma: metastatic risk assessment and management of non-curative resection cases.Clin Endosc2026https://conductscience.org/library/papers/41943646PubMed
41695917Predicting the magnitude of risk for non-curative endoscopic submucosal dissection in superficial esophageal cancer using explainable artificial intelligence.World J Gastrointest Oncol2026https://conductscience.org/library/papers/41695917PubMed
41114901Outcomes of additional chemotherapy for esophageal squamous cell carcinoma following non-curative endoscopic submucosal dissection.Int J Clin Oncol2025https://conductscience.org/library/papers/41114901PubMed
40968731Long-term outcomes of additional surgical versus nonsurgical treatment after non-curative endoscopic resection for T1 superficial esophageal cancer.Int J Surg2026https://conductscience.org/library/papers/40968731PubMed
40646314Endoscopic Submucosal Dissection Followed by Chemoradiotherapy Versus Radiotherapy in Patients with Stage T1bN0M0 Esophageal Cancer.J Gastrointest Cancer2025https://conductscience.org/library/papers/40646314PubMed
40589630Additional chemoradiotherapy following endoscopic submucosal dissection in patients with esophageal squamous cell carcinoma: a narrative review.Front Oncol2025https://conductscience.org/library/papers/40589630PubMed
40002274Esophagectomy Versus Endoscopic Resection with Adjuvant Therapy for T1b/T2 Esophageal Cancer: A Systematic Review and Meta-Analysis.Cancers (Basel)2025https://conductscience.org/library/papers/40002274PubMed
39777993Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma.Thorac Cancer2025https://conductscience.org/library/papers/39777993PubMed
38386660A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC).PLoS One2024https://conductscience.org/library/papers/38386660PubMed
37691683Long-term survival in esophagectomy for early-stage esophageal cancer versus endoscopic resection plus additional chemoradiotherapy: a systematic review and meta-analysis.J Thorac Dis2023https://conductscience.org/library/papers/37691683PubMed
36933136Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.Esophagus2023https://conductscience.org/library/papers/36933136PubMed
36765546Efficacy of Organ Preservation Strategy by Adjuvant Chemoradiotherapy after Non-Curative Endoscopic Resection for Superficial SCC: A Multicenter Western Study.Cancers (Basel)2023https://conductscience.org/library/papers/36765546PubMed
36644141Additional endoscopic treatments for patients with positive lateral margins after endoscopic resection of early esophageal squamous cell carcinoma.Oncol Lett2023https://conductscience.org/library/papers/36644141PubMed
36445654Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.Dig Dis Sci2023https://conductscience.org/library/papers/36445654PubMed
36401267Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes.Radiat Oncol2022https://conductscience.org/library/papers/36401267PubMed
36220991Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.Surg Endosc2023https://conductscience.org/library/papers/36220991PubMed
36205033Clinical models to predict lymph nodes metastasis and distant metastasis in newly diagnosed early esophageal cancer patients: A population-based study.Cancer Med2023https://conductscience.org/library/papers/36205033PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26567992

GET https://conductscience.org/api/papers/v1/26567992/cited_by?page=2